Partnering
In line with the company’s current strategy, Nuformix is developing its pipeline of new drug forms for subsequent out-licensing to pharmaceutical companies.
For more information please contact businessdevelopment@nuformix.com
Latest News
RSS FEED- Jul 30th 2010 - NX006 Pre-Clinical Studies Show 220% Increase in Bioavailability
- Apr 10th 2010 - Nuformix Product Portfolio Growing Beyond Expectations
- Dec 23rd 2009 - Nuformix Files Key Provisional Patent Application for NX006
Nuformix has today received the results from pre-clinical studies for its NX006…more
Nuformix has today filed another significant provisional patent application covering numerous novel solid…more
Nuformix has today filed a provisional patent application covering numerous novel solid forms…more